Ablation of the Oncogenic Transcription Factor ERG by Deubiquitinase Inhibition in Prostate Cancer

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.1322198111
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Abnormal Expression of the ERG Transcription Factor in Prostate Cancer Cells Activates Osteopontin

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2011English

Changes in Cortical Cytoskeletal and Extracellular Matrix Gene Expression in Prostate Cancer Are Related to Oncogenic ERG Deregulation

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

Correction: Colorectal Tumors Are Effectively Eradicated by Combined Inhibition of -Catenin, KRAS, and the Oncogenic Transcription Factor ITF2

Cancer Research
Cancer ResearchOncology
2010English

Disabling an Oncogenic Transcription Factor by Targeting of Control Kinases

Oncotarget
Oncology
2018English

Targeting the Oncogenic TBX2 Transcription Factor With Chromomycins

Frontiers in Chemistry
Chemistry
2020English

The Transcription Factor CUX1 Negatively Regulates Invasion in Castrate Resistant Prostate Cancer

Oncotarget
Oncology
2020English

Molecular Composition of Genomic TMPRSS2-ERG Rearrangements in Prostate Cancer

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2019English

TMPRSS2-ERG Gene Fusion in Transition Zone Prostate Cancer

Modern Pathology
Forensic MedicinePathology
2010English

Regulation of Neural Gene Transcription by Optogenetic Inhibition of the RE1-silencing Transcription Factor

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy